Any comments received by July 9 will be presented directly to the committee
I feel like there's such an interesting dichotomy between the traditional medical world and the integrative medicine world, especially when it comes to something like autism
For example: People on insulin or sulfonylureas, because low blood sugar risk can rise when appetite changes People with kidney concerns, because dehydration can become more dangerous People with significant reflux, because slowed digestion can increase symptoms People with a history of eating disorders, because appetite suppression needs careful oversight Semaglutide eligibility and screening brings these topics into the open early
Cardiovascular Risk Reduction When you combine significant weight loss, improved blood pressure, better lipid profiles, reduced inflammation, and improved glycemic control, the composite cardiovascular risk profile improves substantially
Treatment should be initiated under medical supervision to establish the underlying cause and appropriate dosing schedule
Expected timeline: Days 1-3: Continued acute symptoms, peptide beginning to accumulate Days 4-7: Inflammation reduction often noticeable, pain decreasing Week 2-3: Significant improvement in most acute strains Week 4-6: Return to normal function, consider tapering Complementary approaches: Gentle movement, avoiding complete rest
